Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).
暂无分享，去创建一个
N. Xu | Jianming Xu | Yunpeng Liu | Y. Shu | M. Tao | Linxinyu Xu | Q. Fan | Yi Li | K. Gu | Q. Gao | Hui Zhou | Xiuwen Wang | C. Cui | Tao Zhang | T. Cui | Juxiang Xiao | Yanqi Wang | Zhuo Ma | Yan V. Wang | Zhijun Wu